{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:32:47Z","timestamp":1787610767259,"version":"build-2736575974"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["R.11014\/21\/2023-GIA\/HR"],"award-info":[{"award-number":["R.11014\/21\/2023-GIA\/HR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejphar.2026.178861","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:10:44Z","timestamp":1776237044000},"page":"178861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trace amine associated receptors in neuronal circuits: Mechanistic insights for therapeutic interventions"],"prefix":"10.1016","volume":"1023","author":[{"given":"Mariya","family":"Jahangir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshminarayanan","family":"Gowtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabanita","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumurthy","family":"Velpandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178861_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ijnp\/pyad049","article-title":"In vitro comparison of ulotaront (SEP-363856) and ralmitaront (RO6889450): two TAAR1 agonist candidate antipsychotics","volume":"26","author":"\u00c5gren","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neubiorev.2021.09.020","article-title":"Trace amine-associated receptor 1 (TAAR1): potential application in mood disorders: a systematic review","volume":"131","author":"Alnefeesi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib3","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.1312-15.2015","article-title":"Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission","volume":"35","author":"Alvarsson","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/nutrit\/nuy036","article-title":"Food sources and biomolecular targets of tyramine","volume":"77","author":"Andersen","year":"2019","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fendo.2015.00130","article-title":"Assessing gonadotropin receptor function by resonance energy transfer-based assays","volume":"6","author":"Ayoub","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178861_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-3223(91)90207-3","article-title":"Phenylethylaminergic mechanisms in attention-deficit disorder","volume":"29","author":"Baker","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178861_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/mol.108.048884","article-title":"Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor","volume":"74","author":"Barak","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N\u2010dimethyltryptamines in humans: 1955\u20132010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ejphar.2026.178861_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111576","article-title":"TAAR1 expression in human macrophages and brain tissue: a potential novel facet of MS neuroinflammation","volume":"22","author":"Barnes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/molecules25051054","article-title":"Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6","volume":"25","author":"Bellusci","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178861_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","article-title":"The vesicular monoamine transporter 2: an underexplored pharmacological target","volume":"73","author":"Bernstein","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2026.178861_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02501.x","article-title":"Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators","volume":"90","author":"Berry","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178861_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2016.10.012","article-title":"Trace amine-associated receptor 1 agonists as narcolepsy therapeutics","volume":"82","author":"Black","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178861_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0091-3057(85)90097-8","article-title":"Effects of quipazine and of tryptamine on self-stimulation of median raph\u00e9 nucleus and of lateral hypothalamus in rats","volume":"23","author":"Broadbent","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178861_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N, N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.178861_bib16","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/nu14153118","article-title":"Multiple direct effects of the dietary protoalkaloid N-Methyltyramine in human adipocytes","volume":"14","author":"Carp\u00e9n\u00e9","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2026.178861_bib17","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/s41598-019-42535-w","article-title":"Different circulating trace amine profiles in de novo and treated Parkinson's disease patients","volume":"9","author":"D'Andrea","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178861_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acschemneuro.2c00086","article-title":"Identification of a potent human trace amine-associated receptor 1 antagonist","volume":"13","author":"Decker","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413185","article-title":"Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies","volume":"22","author":"Dedic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.119.260281","article-title":"SEP-363856, a novel psychotropic agent with a unique, non-D2 receptor mechanism of action","volume":"371","author":"Dedic","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00441-020-03331-5","article-title":"Olfactory signaling via trace amine-associated receptors","volume":"383","author":"Dewan","year":"2021","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117774","article-title":"Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5","volume":"10","author":"Dinter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178861_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10571-019-00757-6","article-title":"The action of TAAR1 agonist RO5263397 on executive functions in rats","volume":"40","author":"Dorotenko","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.178861_bib24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4103\/1673-5374.327338","article-title":"Trace amine-associated receptors at the cross-road between innate olfaction of amines, emotions, and adult neurogenesis","volume":"17","author":"Efimova","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib25","first-page":"175","article-title":"Neuronal functions and emerging pharmacology of TAAR1","author":"Espinoza","year":"2017","journal-title":"Tast. Smell"},{"key":"10.1016\/j.ejphar.2026.178861_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.02.010","article-title":"Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1","volume":"93","author":"Espinoza","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib27","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/npp.2015.65","article-title":"TAAR1 modulates cortical glutamate NMDA receptor function","volume":"40","author":"Espinoza","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/npp.2016.233","article-title":"The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats","volume":"42","author":"Ferragud","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178861_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0091-3057(86)90076-6","article-title":"Conditioned taste aversion induced by tryptamine: a temporal analysis","volume":"25","author":"Fletcher","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178861_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.117.015305","article-title":"Trace amines and their receptors","volume":"70","author":"Gainetdinov","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/pr.114.010397","article-title":"Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease","volume":"67","author":"German","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109592","article-title":"Untargeted metabolomics in the aqueous humor reveals the involvement of TAAR pathway in glaucoma","volume":"234","author":"Gowtham","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","article-title":"Trace amine-associated receptor 1\u2014Family archetype or iconoclast?","volume":"116","author":"Grandy","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178861_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tins.2022.10.010","article-title":"Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders","volume":"46","author":"Halff","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(82)90301-6","article-title":"Specific [3H] \u03b2-phenylethylamine binding sites in rat brain","volume":"83","author":"Hauger","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnmol.2018.00213","article-title":"New insights into interactions of presynaptic calcium channel subtypes and SNARE proteins in neurotransmitter release","volume":"11","author":"He","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/bjp.2008.286","article-title":"Dietary trace amine\u2010dependent vasoconstriction in porcine coronary artery","volume":"155","author":"Herbert","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib39","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6488.1000e122","article-title":"Trace amine-associated receptor type 1 as A target for the development of treatments for stimulant abuse","volume":"3","author":"Hiranita","year":"2015","journal-title":"J. Alcohol. drug Depend."},{"key":"10.1016\/j.ejphar.2026.178861_bib40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/schbul\/sbad148","article-title":"Up-regulation of the trace amine receptor, TAAR-1, in the prefrontal cortex of individuals affected by schizophrenia","volume":"50","author":"Imbriglio","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2026.178861_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145799001522","article-title":"Does phenylethylamine act as an endogenous amphetamine in some patients?","volume":"2","author":"Janssen","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-1781(82)90009-9","article-title":"Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patients","volume":"6","author":"Karoum","year":"1982","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopha.2016.07.002","article-title":"The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system","volume":"83","author":"Khan","year":"2016","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178861_bib45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/er.2018-00182","article-title":"3-iodothyronamine\u2014a thyroid hormone metabolite with distinct target profiles and mode of action","volume":"40","author":"K\u00f6hrle","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2021.03.018","article-title":"The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice","volume":"171","author":"Kong","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.178861_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/157340110791233256","article-title":"Toxicological effects of dietary biogenic amines","volume":"6","author":"Ladero","year":"2010","journal-title":"Curr. Nutr. Food Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/13543784.2023.2206559","article-title":"Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials","volume":"32","author":"Le","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2026.178861_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","article-title":"Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors","volume":"81","author":"Leo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib50","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.3390\/ijms23147811","article-title":"Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in alzheimer's disease","volume":"23","author":"Leo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib51","article-title":"Biogenic amines in foods: surveying effective factors and measuring methods","volume":"12","author":"Mahmoudzadeh","year":"2022","journal-title":"J. Microbiol. Biotechnol. Food Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib52","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.3390\/ijms22168907","article-title":"Trace amine-associated receptor 1 contributes to diverse functional actions of O-Phenyl-Iodotyramine in mice but not to the effects of Monoamine-based antidepressants","volume":"22","author":"Mantas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.119.258970","article-title":"The role of biogenic amine transporters in trace amine\u2013associated receptor 1 regulation of methamphetamine-induced neurotoxicity","volume":"371","author":"Miner","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib54","series-title":"Differential Trace Amine Alterations in Individuals Receiving Acetylenic Inhibitors of MAO-A (Clorgyline) or MAO-B (Selegiline and Pargyline)","author":"Murphy","year":"1998"},{"key":"10.1016\/j.ejphar.2026.178861_bib55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acsptsci.2c00016","article-title":"Trace amine-associated receptor 1 (TAAR1): molecular and clinical insights for the treatment of schizophrenia and related comorbidities","volume":"5","author":"Nair","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.178861_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3136\/fstr.26.313","article-title":"N-methyltyramine, a gastrin-releasing factor in beer, and structurally related compounds as agonists for human trace amine-associated receptor 1","volume":"26","author":"Ohta","year":"2020","journal-title":"Food Sci. Technol. Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/acssensors.9b01414","article-title":"\u03b2-Arrestin-2 BRET biosensors detect different \u03b2-arrestin-2 conformations in interaction with GPCRs","volume":"5","author":"Oishi","year":"2019","journal-title":"ACS Sens."},{"key":"10.1016\/j.ejphar.2026.178861_bib59","author":"Oliveira"},{"key":"10.1016\/j.ejphar.2026.178861_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/01677063.2018.1502761","article-title":"Modulation of neuromuscular synapses and contraction in Drosophila 3rd instar larvae","volume":"32","author":"Ormerod","year":"2018","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.ejphar.2026.178861_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/NMM:9:1:55","article-title":"Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models","volume":"9","author":"Paley","year":"2007","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ejphar.2026.178861_bib62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molimm.2006.02.006","article-title":"Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease","volume":"44","author":"Paley","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178861_bib63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","article-title":"Levodopa-induced dyskinesia: clinical features, pathophysiology, and medical management","volume":"20","author":"Pandey","year":"2017","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.ejphar.2026.178861_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2016.00148","article-title":"Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry, and clinical implications","volume":"10","author":"Pei","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib65","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/nu16111567","article-title":"In vitro activation of human adrenergic receptors and trace amine-associated receptor 1 by Phenethylamine analogues present in food supplements","volume":"16","author":"Pinckaers","year":"2024","journal-title":"Nutrients"},{"issue":"206","key":"10.1016\/j.ejphar.2026.178861_bib66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.504988","article-title":"Phenylethylamine in paranoid chronic schizophrenia","volume":"80","author":"Potkin","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.178861_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110555","article-title":"Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD","volume":"117","author":"Raony","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178861_bib68","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/molecules27092755","article-title":"The potential antidepressant action of duloxetine co-administered with the TAAR1 receptor agonist SEP-363856 in mice","volume":"27","author":"Ren","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178861_bib69","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib70","unstructured":"Revel, F.G., Moreau, J.-L., Gainetdinov, R.R., Ferragud, A., Vel\u00e1zquez-S\u00e1nchez, C., Sotnikova, T.D., Morairty, S.R., Harmeier, A., Zbinden, K.G., Norcross, R.D., n.d. Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric."},{"key":"10.1016\/j.ejphar.2026.178861_bib71","doi-asserted-by":"crossref","first-page":"E847","DOI":"10.1208\/aapsj070481","article-title":"Role of monoamine transporters in mediating psychostimulant effects","volume":"7","author":"Riddle","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2026.178861_bib72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/foods8020062","article-title":"Impact of biogenic amines on food quality and safety","volume":"8","author":"Ruiz-Capillas","year":"2019","journal-title":"Foods"},{"key":"10.1016\/j.ejphar.2026.178861_bib73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/nu13010233","article-title":"Effects of p-synephrine during exercise: a brief narrative review","volume":"13","author":"Ruiz-Moreno","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2026.178861_bib74","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3389\/fphar.2017.00987","article-title":"The case for TAAR1 as a modulator of central nervous system function","volume":"8","author":"Rutigliano","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib75","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41386-022-01421-2","article-title":"TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1\/5-HT1A receptor agonist SEP-363856","volume":"47","author":"Saarinen","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1176\/jnp.7.1.6","article-title":"Phenylethylamine modulation of affect: therapeutic and diagnostic implications","volume":"7","author":"Sabelli","year":"1995","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178861_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100174","article-title":"Application of FRET-and BRET-based live-cell biosensors in deorphanization and ligand discovery studies on orphan G protein-coupled receptors","author":"Sajkowska","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejphar.2026.178861_bib78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fendo.2012.00105","article-title":"BRET biosensors to study GPCR biology, pharmacology, and signal transduction","volume":"3","author":"Salahpour","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178861_bib79","first-page":"321","article-title":"AKAP signaling complexes in regulation of excitatory synaptic plasticity","volume":"17","author":"Sanderson","year":"2011","journal-title":"Neurosci"},{"key":"10.1016\/j.ejphar.2026.178861_bib80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/278357a0","article-title":"Deficient production of tyramine and octopamine in cases of depression","volume":"278","author":"Sandler","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178861_bib81","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/npp.2016.216","article-title":"Trace amine-associated receptor 1 regulates wakefulness and EEG spectral composition","volume":"42","author":"Schwartz","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib82","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/biomedicines12061263","article-title":"TAARs as novel therapeutic targets for the treatment of depression: a narrative review of the interconnection with monoamines and adult neurogenesis","volume":"12","author":"Shemiakova","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178861_bib83","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217396120","article-title":"Octopamine metabolically reprograms astrocytes to confer neuroprotection against \u03b1-synuclein","volume":"120","author":"Shum","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib84","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.115.229765","article-title":"In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1","volume":"357","author":"Simmler","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/foods8080306","article-title":"Biogenic amines, phenolic, and aroma-related compounds of unroasted and roasted cocoa beans with different origin","volume":"8","author":"Spizzirri","year":"2019","journal-title":"Foods"},{"key":"10.1016\/j.ejphar.2026.178861_bib86","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ptr.5879","article-title":"Safety, efficacy, and mechanistic studies regarding Citrus aurantium (bitter orange) extract and p\u2010synephrine","volume":"31","author":"Stohs","year":"2017","journal-title":"Phyther. Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib87","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/ptr.6649","article-title":"p\u2010Synephrine, ephedrine, p\u2010octopamine and m\u2010synephrine: comparative mechanistic, physiological and pharmacological properties","volume":"34","author":"Stohs","year":"2020","journal-title":"Phyther. Res."},{"key":"10.1016\/j.ejphar.2026.178861_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105271","article-title":"T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex","volume":"151","author":"Tozzi","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.178861_bib89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/biom12010114","article-title":"Deregulation of trace amine-associated receptors (TAAR) expression and signaling mode in melanoma","volume":"12","author":"Vaganova","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.178861_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313216","article-title":"Functional analysis of TAAR1 expression in the intestine wall and the effect of its gene knockout on the gut Microbiota in mice","volume":"25","author":"Vaganova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178861_bib91","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jinsphys.2010.05.018","article-title":"The role of octopamine in locusts and other arthropods","volume":"56","author":"Verlinden","year":"2010","journal-title":"J. Insect Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178861_bib92","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.106.112532","article-title":"Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1","volume":"320","author":"Wainscott","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1476-5381.1970.tb10340.x","article-title":"The action of para-methoxyphenylethylamine (PMPEA) on monosynaptic reflex transmission in the cat","volume":"38","author":"Walker","year":"1970","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173862","article-title":"TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid","volume":"245","author":"Wang","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178861_bib95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/01677063.2020.1868457","article-title":"She's got nerve: roles of octopamine in insect female reproduction","volume":"35","author":"White","year":"2021","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.ejphar.2026.178861_bib96","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/jsfa.10928","article-title":"Biogenic amines: formation, action and toxicity\u2013a review","volume":"101","author":"W\u00f3jcik","year":"2021","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.ejphar.2026.178861_bib97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-3623(83)90020-4","article-title":"Phenylethylamine in neuropsychiatric disorders","volume":"14","author":"Wolf","year":"1983","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"key":"10.1016\/j.ejphar.2026.178861_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer's diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.178861_bib99","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s40263-021-00871-4","article-title":"Potential of ligands for trace amine-associated receptor 1 (TAAR1) in the management of substance use disorders","volume":"35","author":"Wu","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.178861_bib100","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00213-021-05937-1","article-title":"The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice","volume":"238","author":"Wu","year":"2021","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.ejphar.2026.178861_bib101","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bcp.2009.05.031","article-title":"Trace amine-associated receptor 1 as a monoaminergic modulator in brain","volume":"78","author":"Xie","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178861_bib102","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/jpet.107.134247","article-title":"\u03b2-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain","volume":"325","author":"Xie","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.106.117382","article-title":"Trace amine-associated receptor 1 is a modulator of the dopamine transporter","volume":"321","author":"Xie","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178861_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2017.11.012","article-title":"Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: effects of the TAAR 1 agonist RO5263397","volume":"129","author":"Xue","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178861_bib105","series-title":"Pharmacological Treatment of Parkinson's Disease","first-page":"129","author":"Zahoor","year":"2018"},{"key":"10.1016\/j.ejphar.2026.178861_bib106","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","article-title":"Role of dopamine in the pathophysiology of Parkinson's disease","volume":"12","author":"Zhou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.178861_bib107","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphys.2014.00402","article-title":"Update on 3-iodothyronamine and its neurological and metabolic actions","volume":"5","author":"Zucchi","year":"2014","journal-title":"Front. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:01:18Z","timestamp":1778724078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":106,"alternative-id":["S0014299926003432"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178861","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trace amine associated receptors in neuronal circuits: Mechanistic insights for therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178861"}}